SEC 13F Intelligence

Commodore Capital LP / STSAUSD

Commodore Capital LP’s Satsuma Pharmaceuticals Inc Position

Does Commodore Capital LP own Satsuma Pharmaceuticals Inc (STSAUSD)? Not currently — the last reported position was 3.71M shares worth $22M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$22M
Q3 2022
Shares
3.71M
% of Portfolio
+3.58%
Quarters Held
7
position exited

Position History STSAUSD

Reported value by quarter
Q1 ’21: $14MQ1 ’21Q2 ’21: $22MQ2 ’21Q3 ’21: $15MQ3 ’21Q4 ’21: $17MQ4 ’21Q1 ’22: $14MQ1 ’22Q2 ’22: $15MQ2 ’22Q3 ’22: $22MQ3 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20223.71M$22M+3.58%
Q2 20223.71M$15M+3.25%
Q1 20223.71M$14M+3.15%
Q4 20213.71M$17M+3.87%
Q3 20213.12M$15M+3.83%
Q2 20213.10M$22M+7.52%
Q1 20212.43M$14M+5.66%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Commodore Capital LP’s full portfolio or all institutional holders of STSAUSD.